Shanghai RAAS Blood Products Co., Ltd.
002252
Rangering i aksjer
#3635
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aksjekurs
$0.70717976
Markedsverdi
$4.66B
Endring (1 dag)
-0.20%
Endring (1 år)
-24.51%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
EPS for Shanghai RAAS Blood Products Co., Ltd. (002252)
EPS per June 2026 TTM: $0.03
Ifølge de siste økonomiske rapportene og aksjekursen til Shanghai RAAS Blood Products Co., Ltd. er selskapets nåværende EPS (TTM) $0.03. Ved slutten av 2023 hadde selskapet en EPS på $0.04, lik EPS-en i 2022 som var $0.04.
EPS-historikk for Shanghai RAAS Blood Products Co., Ltd. fra 2005 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.03 | -47.80% |
| 2024 | $0.05 | 18.64% |
| 2023 | $0.04 | -6.16% |
| 2022 | $0.04 | 34.44% |
| 2021 | $0.03 | 0.33% |
| 2020 | $0.03 | 75.00% |
| 2019 | $0.02 | -138.14% |
| 2018 | $-0.05 | -272.80% |
| 2017 | $0.03 | -45.05% |
| 2016 | $0.05 | 6.26% |
| 2015 | $0.04 | 130.41% |
| 2014 | $0.02 | 203.13% |
| 2013 | $0.01 | -37.25% |
| 2012 | $0.01 | 12.09% |
| 2011 | $0.01 | 13.75% |
| 2010 | $0.01 | 40.35% |
| 2009 | $0.01 | 14.00% |
| 2008 | $0.01 | 19.05% |
| 2007 | 0.00 | -38.24% |
| 2006 | $0.01 | 3.03% |
| 2005 | $0.01 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $17.32 | 66,260.15% |
US
|
|
| $-7.98 | -30,674.71% |
US
|
|
| $-5.29 | -20,368.20% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 106,183.52% |
NL
|
